Personensuche
Personensuche
Es wurde 1 Person gefunden.
Telefon
Funktionen
-
Direktor/in, Institut für Pathologie
-
Professorinnen/Professoren, Fachbereichsrat
-
Stellv. Ärztlicher Direktor, Dekanat Medizin
Aktuelle Veranstaltungen
-
WiSe 2025
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
-
WiSe 2024
- Klinisch-neuropathologische Konferenz (*)
- Klinisch-pathologische Konferenz (PV)
- Endokrines Tumorzentrum am WTZ und ENETS-Center of Excellence
- Pathologie I (Begleitvorlesung zum Kurs)
- Pathologie II (Begleitvorlesung zum Kurs)
- Pathologie I (PV)
- Problemfallbesprechung am Diskussionsmikroskop (*)
- Klinisch-pathologische Demonstration von Obduktionsfällen(*)
-
SoSe 2024
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Autoimmune thyroiditis in paediatric thyroid cancer : clinical features and outcomesIn: European Journal of Endocrinology (EJE), Jg. 193, 2025, Nr. 1, S. 48 – 55
-
Subsequent Thyroid Carcinomas in Children and Adolescents Registered in the German MET Consortium (1997-2023)In: Thyroid, Jg. 35, 2025, Nr. 1, S. 18 – 30
-
Impact of ¹⁸F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer : Results from a Prospective Double-Center TrialIn: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 12, S. 1855 – 1861
-
A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinomaIn: Journal of Cancer Research and Clinical Oncology, Jg. 149, 2023, Nr. 8, S. 5085 – 5094DOI (Open Access)
-
Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy ProtocolsIn: Oncology Research and Treatment, Jg. 46, 2023, Nr. 4, S. 140 – 150
-
Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world settingIn: Journal of Cancer Research and Clinical Oncology, Jg. 149, 2023, Nr. 11, S. 9243 – 9252DOI (Open Access)
-
Fibroblast activation protein-α expression in fibroblasts is common in the tumor microenvironment of colorectal cancer and may serve as a therapeutic targetIn: Pathology & Oncology Research, Jg. 29, 2023, 1611163DOI (Open Access)
-
Hemithyreoidektomie oder totale Thyreoidektomie beim papillären Niedrigrisikokarzinom der Schilddrüse? : Chirurgische Kriterien der primären und sekundären Therapiewahl im interdisziplinären BehandlungskonzeptIn: Die Chirurgie, Jg. 94, 2023, Nr. 1, S. 79 – 92
-
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapyIn: Journal of Cancer Research and Clinical Oncology, Jg. 149, 2023, Nr. 8, S. 4315 – 4325DOI (Open Access)
-
Sporadic noninvasive medullary thyroid neoplasm : A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomyIn: Surgery, Jg. 174, 2023, Nr. 6, S. 1356 – 1362
-
Tumor cell cytoplasmic metallothionein expression associates with differential tumor immunogenicity and prognostic outcome in high-grade serous ovarian carcinomaIn: Frontiers in Oncology, Jg. 13, 2023, 1252700DOI (Open Access)
-
Abandoning node dissection for desmoplasia-negative encapsulated unifocal sporadic medullary thyroid cancerIn: Surgery, Jg. 171, 2022, Nr. 2, S. 360 – 367
-
Age, American Thyroid Association Risk Group, and Response to Therapy Are Prognostic Factors in Children With Differentiated Thyroid CancerIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 107, 2022, Nr. 1, S. e165 – e177DOI (Open Access)
-
CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian CancerIn: Frontiers in Oncology, Jg. 12, 2022, 798680DOI, Online Volltext (Open Access)
-
Cancer-Associated Fibroblasts Regulate Kinase Activity in Mesothelioma Cell Lines via Paracrine Signaling and Thereby Dictate Cell Faith and BehaviorIn: International Journal of Molecular Sciences (IJMS), Jg. 23, 2022, Nr. 6, 3278DOI (Open Access)
-
Clonidine suppression test for a reliable diagnosis of pheochromocytoma : When to useIn: Clinical Endocrinology, Jg. 97, 2022, Nr. 5, S. 541 – 550DOI (Open Access)
-
Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapyIn: BMC Cancer, Jg. 22, 2022, Nr. 1, 46DOI, Online Volltext (Open Access)
-
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI) : A Single-Center Prospective Two-Arm StudyIn: Clinical Cancer Research, Jg. 28, 2022, Nr. 19, S. 4194 – 4202DOI (Open Access)
-
First report from the German COVID-19 autopsy registryIn: The Lancet Regional Health - Europe, Jg. 15, 2022, 100330DOI (Open Access)
-
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World SettingIn: International Journal of Molecular Sciences (IJMS), Jg. 23, 2022, Nr. 15, 8716DOI (Open Access)
-
Multimodal survival prediction in advanced pancreatic cancer using machine learningIn: ESMO Open, Jg. 7, 2022, Nr. 5, 100555DOI, Online Volltext (Open Access)
-
Optimisation of the Chicken Chorioallantoic Membrane Assay in Uveal Melanoma ResearchIn: Pharmaceutics, Jg. 14, 2022, Nr. 1, 13DOI, Online Volltext (Open Access)
-
Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implicationsIn: Lung Cancer, Jg. 168, 2022, S. 10 – 20
-
Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapyIn: Endocrine, Jg. 75, 2022, Nr. 1, S. 293 – 302DOI (Open Access)
-
Analysis of risk factors and prognosis in differentiated thyroid cancer with focus on minimal extrathyroidal extensionIn: BMC Endocrine Disorders, Jg. 21, 2021, Nr. 1, 161DOI, Online Volltext (Open Access)
-
Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition : Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 ImmunohistochemistryIn: Frontiers in Oncology, Jg. 11, 2021, 725549DOI, Online Volltext (Open Access)
-
BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapyIn: European Journal of Cancer (EJC), Jg. 149, 2021, S. 211 – 221
-
Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapyIn: Journal of Cancer Research and Clinical Oncology, Jg. 147, 2021, Nr. 2, S. 579 – 591DOI (Open Access)
-
Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma : Lessons From Individual Cases With Long-Term Follow-UpIn: Frontiers in Endocrinology, Jg. 12, 2021, 718418DOI, Online Volltext (Open Access)
-
Diagnostische Grundlagen von Schilddrüsentumoren in der Pathologie : Relevante Änderungen durch die aktuelle WHO-KlassifikationIn: Der Pathologe, Jg. 42, 2021, Nr. 1, S. 125 – 139
-
Digital gene expression analysis of epithelioid and sarcomatoid mesothelioma reveals differences in immunogenicityIn: Cancers, Jg. 13, 2021, Nr. 8, S. 1761DOI (Open Access)
-
Dll3 (Delta-like protein 3) expression correlates with stromal desmoplasia and lymph node metastases in medullary thyroid carcinomasIn: Endocrine Connections, Jg. 10, 2021, Nr. 3, S. 283 – 289DOI (Open Access)
-
Electrochemotherapy with bleomycin enhances radiosensitivity of uveal melanomas : First in vitro results in 3d cultures of primary uveal melanoma cell linesIn: Cancers, Jg. 13, 2021, Nr. 12, 3086DOI (Open Access)
-
Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including CetuximabIn: Frontiers in Oncology, Jg. 11, 2021, 635096DOI, Online Volltext (Open Access)
-
Management of primary and renal hyperparathyroidism : Guidelines from the German Association of Endocrine Surgeons (CAEK)In: Langenbeck's Archives of Surgery, Jg. 406, 2021, S. 571 – 585
-
Nodulärer Tumor eines Ductus deferens mit epithelialen VerbändenIn: Der Pathologe, Jg. 42, 2021, Nr. 6, S. 598 – 601
-
Pulmonary echinococcosis : A rare pseudotumour of the lungIn: Rare Tumors, Jg. 13, 2021, S. 1 – 5DOI (Open Access)
-
Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus TrametinibIn: Clinical Cancer Research, Jg. 27, 2021, Nr. 16, S. 4500 – 4510DOI (Open Access)
-
Therapeutic Effect of Combined Dabrafenib and Trametinib Treatment of BRAF V600E-Mutated Primary Squamous Cell Carcinoma of the Thyroid : A Case ReportIn: European Thyroid Journal, Jg. 10, 2021, Nr. 6, S. 511 – 516DOI (Open Access)
-
A novel epitope quality-based immune escape mechanism reveals patient’s suitability for immune checkpoint inhibitionIn: Cancer Management and Research, Jg. 12, 2020, S. 7881 – 7890DOI (Open Access)
-
Acute myeloid leukemia–induced remodeling of the human bone marrow niche predicts clinical outcomeIn: Blood Advances, Jg. 4, 2020, Nr. 20, S. 5257 – 5268DOI (Open Access)
-
An Animal Model Further Uncovers the Role of Mutant BrafV⁶⁰⁰E during Papillary Thyroid Cancer DevelopmentIn: The American Journal of Pathology, Jg. 190, 2020, Nr. 3, S. 702 – 710DOI (Open Access)
-
Angiomyolipom der Leber : Ein Fallbericht in Zusammenschau mit der LiteraturIn: Der Pathologe, Jg. 41, 2020, Nr. 6, S. 643 – 648
-
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer : The CEBIFOX TrialIn: Clinical Colorectal Cancer, Jg. 19, 2020, Nr. 4, S. 236 – 247.e6
-
Characterization of two types of intranuclear hepatocellular inclusions in NAFLDIn: Scientific Reports, Jg. 10, 2020, Nr. 1, S. 16533DOI (Open Access)
-
Correction to: : The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrenceIn: World Journal of Urology, 2020DOI (Open Access)
-
Differentiating Benign from Malignant Adrenocortical Tumors by a Single Morphological Parameter—a Clinicopathological Study on 837 Adrenocortical NeoplasiasIn: Indian Journal of Surgical Oncology, Jg. 11, 2020, Nr. 4, S. 705 – 710DOI (Open Access)
-
Ektopes Schilddrüsengewebe in der Nebenniere : Ein Fallbericht in Zusammenschau mit der LiteraturIn: Der Pathologe, Jg. 41, 2020, Nr. 2, S. 177 – 180
-
HDAC Inhibition Induces PD-L1 Expression in a Novel Anaplastic Thyroid Cancer Cell LineIn: Pathology & Oncology Research, Jg. 26, 2020, Nr. 4, S. 2523 – 2535DOI (Open Access)
-
Immunohistochemical Profile and 47-Gene Next-Generation Sequencing (NGS) Solid Tumor Panel Analysis of a Series of 13 Strumal CarcinoidsIn: Endocrine Pathology, Jg. 31, 2020, S. 101 – 107DOI (Open Access)
-
Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesotheliomaIn: Scientific Reports, Jg. 10, 2020, Nr. 1, S. 18677DOI, Online Volltext (Open Access)
-
Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression contextIn: European Journal of Cancer (EJC), Jg. 140, 2020, S. 76 – 85
-
Neuroendokrine Neoplasien des VerdauungstraktsIn: Best Practice Onkologie, Jg. 15, 2020, Nr. 7-8, S. 320 – 333
-
Pathologie und molekulares Profil differenzierter SchilddrüsenkarzinomeIn: Der Chirurg, Jg. 91, 2020, Nr. 12, S. 999 – 1006
-
Phäochromozytomatose nach Adrenalektomie : Metastasierung oder Zellverschleppung?In: Der Chirurg, Jg. 91, 2020, Nr. 4, S. 345 – 353
-
Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxinIn: Molecular Oncology, Jg. 14, 2020, Nr. 2, S. 261 – 276DOI (Open Access)
-
The mismatch repair system is not affected in medullary thyroid carcinoma independent of stromal desmoplasia or ret proto-oncogene mutationIn: Annals of Diagnostic Pathology, Jg. 44, 2020, 151445
-
Urachal cancer in Germany and the USA : An RKI/SEER population-based comparison studyIn: Urologia Internationalis, Jg. 104, 2020, Nr. 9-10, S. 803 – 809
-
β-catenin in intranuclear inclusions of hepatocellular carcinomaIn: Hepatoma Research, Jg. 6, 2020, 41DOI (Open Access)
-
Anaplastisches Schilddrüsenkarzinom – Update 2019In: Der Onkologe, Jg. 25, 2019, Nr. 7, S. 569 – 572
-
Auswirkungen für die Beurteilung der Feinnadelbiopsie der Schilddrüse nach der Einführung der NIFTPIn: Der Onkologe, Jg. 25, 2019, Nr. 7, S. 590 – 595
-
Bortezomib sensitivity is tissue dependent and high expression of the 20S proteasome precludes good response in malignant pleural mesotheliomaIn: Cancer Management and Research, Jg. 11, 2019, S. 8711 – 8720DOI (Open Access)
-
Digital immune-related gene expression signatures in high-grade serous ovarian carcinoma : Developing prediction models for platinum responseIn: Cancer Management and Research, Jg. 11, 2019, S. 9571 – 9583DOI, Online Volltext (Open Access)
-
Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancerIn: BMC Cancer, Jg. 19, 2019, Nr. 1, S. 120DOI (Open Access)
-
Eröffnungsrede des Tagungspräsidenten der Deutschen Gesellschaft für PathologieIn: Der Pathologe, Jg. 40, 2019, Nr. Suppl. 3, S. 220 – 222
-
Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitroIn: BMC Cancer, Jg. 19, 2019, Nr. 1, 108DOI (Open Access)
-
Impact of RAS mutation subtype on clinical outcome : A cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancerIn: Oncogene, Jg. 38, 2019, Nr. 16, S. 2953 – 2966
-
Increased Anaplastic Lymphoma Kinase Activity Induces a Poorly Differentiated Thyroid Carcinoma in MiceIn: Thyroid, Jg. 29, 2019, Nr. 10, S. 1438 – 1446DOI, Online Volltext (Open Access)
-
Intranuclear inclusions in hepatocellular carcinoma contain autophagy-associated proteins and correlate with prolonged survivalIn: The Journal of Pathology: Clinical Research, Jg. 5, 2019, Nr. 3, S. 164 – 176DOI, Online Volltext (Open Access)
-
Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocolsIn: Journal of Cancer Research and Clinical Oncology, Jg. 145, 2019, Nr. 2, S. 445 – 455
-
Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancerIn: Annals of Oncology, Jg. 30, 2019, Nr. 4, S. 655 – 657DOI (Open Access)
-
Morphologische Diagnosekriterien der nichtinvasiven follikulären Neoplasie mit PTC-äquivalenten Kernmerkmalen (NIFTP) : Eine diagnostische Herausforderung zum Nutzen des PatientenIn: Der Pathologe, Jg. 40, 2019, Nr. 3, S. 220 – 226
-
Morphology and etiology of pheochromocytomaIn: Der Pathologe, Jg. 40, 2019, Nr. Suppl. 3, S. 316 – 317
-
New insights into intranuclear inclusions in thyroid carcinoma : Association with autophagy and with BRAFV⁶⁰⁰E mutationIn: PLoS ONE, Jg. 14, 2019, Nr. 12, S. 0226199DOI (Open Access)
-
Papilloma of the Fallopian Tube : A Rare Gynecologic Neoplasm Harboring a BRAF (c.1799T>A) Mutation (V600E)In: International Journal of Gynecological Pathology, Jg. 38, 2019, Nr. 5, S. 459 – 463
-
Primäres Meningeom des Nervus opticus im Säuglingsalter als Erstmanifestation einer Neurofibromatose Typ 2In: Der Pathologe, Jg. 40, 2019, Nr. 2, S. 179 – 184
-
Prognostic significance of PD-1 and PD-L1 positive tumor-infiltrating immune cells in ovarian carcinomaIn: International Journal of Gynecological Cancer, Jg. 29, 2019, Nr. 9, S. 1389 – 1395
-
Proposal for an extended pTNM classification of thyroid carcinoma : commentary on deficits of the 8th edition of the TNM classificationIn: Der Pathologe, Jg. 40, 2019, Nr. Supplement 1, S. 18 – 24DOI (Open Access)
-
Screening of Pleural Mesothelioma Cell Lines for Kinase Activity May Identify New Mechanisms of Therapy Resistance in Patients Receiving Platin-Based ChemotherapyIn: Journal of Oncology, 2019, 2902985DOI (Open Access)
-
Setting out the frame conditions for feasible use of FFPE derived RNAIn: Pathology, Research and Practice, Jg. 215, 2019, Nr. 2, S. 381 – 386
-
The GNAS SNP c.393C>T (rs7121) as a marker for disease progression and survival in cancerIn: Pharmacogenomics, Jg. 20, 2019, Nr. 7, S. 553 – 562
-
Thyroxine promotes lung cancer growth in an orthotopic mouse modelIn: Endocrine-Related Cancer, Jg. 26, 2019, Nr. 6, S. 565 – 574DOI (Open Access)
-
Warum muss ein Schilddrüsentumor als Karzinom klassifiziert werden, wenn er sich biologisch nicht wie Krebs verhält? : Nichtinvasive follikuläre Neoplasie mit PTC-äquivalenten Kernmerkmalen als VorbildIn: Der Onkologe, Jg. 25, 2019, Nr. 7, S. 580 – 589
-
Aktualisierung der S2k-Leitlinie : Operative Therapie benigner SchilddrüsenerkrankungenIn: Der Chirurg, Jg. 89, 2018, Nr. 9, S. 699 – 709
-
Ektopes Gewebe der Schilddrüse und der NebenschilddrüsenIn: Der Pathologe, Jg. 39, 2018, Nr. 5, S. 379 – 389
-
Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapyIn: OncoTarget, Jg. 9, 2018, Nr. 32, S. 22254 – 22268DOI (Open Access)
-
Inhibition of MDM2 via Nutlin-3A : A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53In: Journal of Oncology, 2018, 1986982DOI (Open Access)
-
MET Expression in Advanced Non–Small-Cell Lung Cancer : Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and ImmunotherapyIn: Clinical Lung Cancer, Jg. 19, 2018, Nr. 4, S. e441 – e463
-
Mangel an lysosomaler saurer Lipase (LAL-D) : Diagnostik und aktuelle Therapie einer unterdiagnostizierten ErkrankungIn: Der Pathologe, Jg. 39, 2018, Nr. 3, S. 249 – 254
-
Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancerIn: PLoS ONE, Jg. 13, 2018, Nr. 5, S. e0195716DOI (Open Access)
-
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomasIn: International Journal of Cancer, Jg. 143, 2018, Nr. 7, S. 1764 – 1773DOI, Online Volltext (Open Access)
-
Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal CancerIn: Clinical Colorectal Cancer, Jg. 17, 2018, Nr. 2, S. e331 – e352
-
Processing Escape Mechanisms Through Altered Proteasomal Cleavage of Epitopes Affect Immune Response in Pulmonary Neuroendocrine TumorsIn: Technology in Cancer Research & Treatment (TCRT), Jg. 17, 2018DOI (Open Access)
-
Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung AdenocarcinomaIn: Clinical Lung Cancer, Jg. 19, 2018, Nr. 6, S. e879 – e884
-
Vorschlag zu einer erweiterten pTNM-Klassifikation der Schilddrüsenkarzinome : Kommentar zu Defiziten der 8. Auflage der TNM-KlassifikationIn: Der Pathologe, Jg. 39, 2018, Nr. 1, S. 49 – 56
-
Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor, synchronous axillary lymph node metastases and circulating tumor cells in early breast cancer patientsIn: Cancer Research, Jg. 77, 2017, Nr. 4, S. P1 – 01
-
Comprehensive biomarker analyses in patients with advanced or metastatic non-small cell lung cancer prospectively treated with the polo-like Kinase 1 Inhibitor BI2536In: Oncology Research and Treatment, Jg. 40, 2017, Nr. 7-8, S. 435 – 439
-
Curcumin induces G2/M arrest, apoptosis, NF-kB inhibition, and expression of differentiation genes in thyroid carcinoma cellsIn: Journal of Cancer Research and Clinical Oncology, Jg. 143, 2017, Nr. 7, S. 1143 – 1154
-
Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitisIn: European Journal of Cancer (EJC), Jg. 86, 2017, S. 248 – 256
-
Definition der R1-Resektion bei SchilddrüsenkarzinomenIn: Der Chirurg, Jg. 88, 2017, Nr. 9, S. 740 – 747
-
Differential regulation of monocarboxylate transporter 8 expression in thyroid cancer and hyperthyroidismIn: European Journal of Endocrinology (EJE), Jg. 177, 2017, Nr. 3, S. 243 – 250
-
Erratum to: Curcumin induces G2/M arrest, apoptosis, NF-kB inhibition, and expression of differentiation genes in thyroid carcinoma cellsIn: Journal of Cancer Research and Clinical Oncology, Jg. 143, 2017, Nr. 7, S. 1155 – 1156
-
Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesotheliomaIn: OncoTarget, Jg. 8, 2017, Nr. 23, S. 37502 – 37510DOI (Open Access)
-
High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung CancerIn: Journal of Thoracic Oncology, Jg. 12, 2017, Nr. 1, S. 54 – 64DOI (Open Access)
-
Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladderIn: Journal of Cancer Research and Clinical Oncology, Jg. 143, 2017, Nr. 9, S. 1659 – 1670
-
Intermediate microRNA expression profile in Graves' disease falls between that of normal thyroid tissue and papillary thyroid carcinomaIn: Journal of Clinical Pathology: JCP Online, Jg. 70, 2017, Nr. 1, S. 33 – 39
-
Max Schottelius: Pioneer in PheochromocytomaIn: Journal of the Endocrine Society, Jg. 1, 2017, Nr. 7, S. 957 – 964DOI (Open Access)
-
Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapyIn: OncoTarget, Jg. 8, 2017, Nr. 28, S. 45898 – 45917DOI (Open Access)
-
Molekulare Pathogenese von Schilddrüsenknoten – Bedeutung für die klinische VersorgungIn: Laryngo-Rhino-Otologie, Jg. 96, 2017, Nr. 9, S. 590 – 596
-
NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinomaIn: OncoTarget, Jg. 8, 2017, Nr. 26, S. 42613 – 42620DOI (Open Access)
-
Papillary thyroid cancer and coexisting autoimmune thyroiditisIn: Hormone and Metabolic Research, Jg. 49, 2017, Nr. 11, S. 869 – 872
-
Rapid and Highly Sensitive EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA Specimen of Lung AdenocarcinomaIn: Journal of Thoracic Oncology, Jg. 12, 2017, Nr. Suppl. 1, S. S1201 – S1201
-
miRNA regulation is important for DNA damage repair and recognition in malignant pleural mesotheliomaIn: Virchows Archiv, Jg. 470, 2017, Nr. 6, S. 627 – 637
-
A 6-Base Pair in Frame Germline Deletion in Exon 7 Of RET Leads to Increased RET Phosphorylation, ERK Activation, and MEN2AIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 101, 2016, Nr. 3, S. 1016 – 1022DOI (Open Access)
-
ACTB, CDKN1B, GAPDH, GRB2, RHOA and SDCBP Were Identified as Reference Genes in Neuroendocrine Lung Cancer via the nCounter TechnologyIn: PLoS ONE, Jg. 11, 2016, Nr. 11, S. e0165181DOI (Open Access)
-
Caspase-8 Polymorphisms As Independent Prongostic Factors For Survival In Breast Cancer PatientsIn: International Journal of Gynecological Cancer, Jg. 26, 2016, Nr. Suppl. 2, S. 30
-
Cetuximab biweekly (q2w) plus mFOLFOX6 as 1st line therapy in patients (pts) with KRAS wild-type (wt) (exon 2) metastatic colorectal cancer (mCRC) – Primary endpoint and subgroup analysis of the CEBIFOX trialIn: Annals of Oncology, Jg. 27, 2016, Nr. Suppl.6, S. 508P
-
Folic-acid metabolism and DNA-repair phenotypes differ between neuroendocrine lung tumors and associate with aggressive subtypes, therapy resistance and outcomeIn: OncoTarget, Jg. 7, 2016, Nr. 15, S. 20166 – 20179DOI (Open Access)
-
Investigation of pharmaceutical targets in pulmonary neuroendocrine tumors by massive parallel sequencing and digital gene expression analysisIn: Oncology Research and Treatment, Jg. 39, 2016, Nr. Suppl. 1, S. 26 – 26
-
MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal CancerIn: PLoS ONE, Jg. 11, 2016, Nr. 6, S. e0156871DOI (Open Access)
-
Pediatric differentiated thyroid carcinoma in The Netherlands : A nationwide follow-up studyIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 101, 2016, Nr. 5, S. 2031 – 2039DOI (Open Access)
-
Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational statusIn: World Journal of Surgical Oncology, Jg. 14, 2016, Nr. 1, S. 189DOI (Open Access)
-
Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancerIn: BMC Cancer, Jg. 16, 2016, S. 618DOI (Open Access)
-
Screening of Pleural Mesotheliomas for DNA-damage Repair Players by Digital Gene Expression Analysis Can Enhance Clinical Management of Patients Receiving Platin-Based ChemotherapyIn: Journal of Cancer, Jg. 7, 2016, Nr. 13, S. 1915 – 1925DOI, Online Volltext (Open Access)
-
Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancerIn: The Prostate, Jg. 76, 2016, Nr. 11, S. 977 – 985
-
Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancerIn: Endocrine, Jg. 54, 2016, Nr. 3, S. 733 – 741
-
microRNAs are differentially regulated between MDM2-positive and negative malignant pleural mesotheliomaIn: OncoTarget, Jg. 7, 2016, Nr. 14, S. 18713 – 18721
-
AQP1, AQP5, Bcl-2 and p16 in pharyngeal squamous cell carcinomaIn: The Journal of Laryngology and Otology, Jg. 129, 2015, Nr. 6, S. 580 – 586
-
Cetuximab biweekly plus mFOLFOX6 as first-line therapy in patients (pts) with KRAS wild-type (wt) (exon 2) metastatic colorectal cancer (mCRC) : Primary endpoint and subgroup analysis of the CEBIFOX trialIn: Journal of Clinical Oncology (JCO), Jg. 33, 2015, Nr. 15 Suppl., S. 3568
-
Die C-Zellen der Schilddrüse und ihre Pathologie : Teil 2: Medulläres Karzinom der SchilddrüseIn: Der Pathologe, Jg. 36, 2015, Nr. 3, S. 254 – 260
-
Die C-Zellen der Schilddrüse und ihre Pathologie : Teil 1: Normale C-Zellen – Hyperplasie der C-Zellen – Präkanzerose des familiären medullären KarzinomsIn: Der Pathologe, Jg. 36, 2015, Nr. 3, S. 246 – 253
-
Erratum zu: Die C-Zellen der Schilddrüse und ihre Pathologie : Teil 1: Normale C-Zellen – Hyperplasie der C-Zellen – Präkanzerose des familiären medullären KarzinomsIn: Der Pathologe, Jg. 36, 2015, Nr. 6, S. 571
-
Expression of the cAMP binding protein EPAC1 in thyroid tumors and growth regulation of thyroid cells and thyroid carcinoma cells by EPAC proteinsIn: Hormone and Metabolic Research, Jg. 47, 2015, Nr. 3, S. 200 – 208
-
Identification of deregulation of apoptosis and cell cycle in neuroendocrine tumors of the lung via NanoString nCounter expression analysisIn: OncoTarget, Jg. 6, 2015, Nr. 28, S. 24690 – 24698DOI (Open Access)
-
Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningiomaIn: Neuropathology, Jg. 35, 2015, Nr. 1, S. 24 – 36
-
Intraoperativer Gefrierschnitt der SchilddrüseIn: Der Pathologe, Jg. 36, 2015, Nr. 4, S. 362 – 371
-
Klinische Bedeutung der SchilddrüsenzytologieIn: Der Pathologe, Jg. 36, 2015, Nr. 6, S. 543 – 552
-
Lymphknoten- und Organmetastasen des Schilddrüsenkarzinoms: Metastasen in der Schilddrüse : Lymph node and distant metastases of thyroid gland cancer: Metastases in the thyroid glandsIn: Der Pathologe, Jg. 36, 2015, Nr. Supplement 2, S. 171 – 175
-
MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53In: British Journal of Cancer (BJC), Jg. 112, 2015, Nr. 5, S. 883 – 890DOI (Open Access)
-
Molecular dissection of the impact of frequent genetic alterations on the response of head and neck cancers to anti-epidermal growth factor receptor-directed therapiesIn: Oral Oncology, Jg. 51, 2015, Nr. 5, S. e39
-
Molekularpathogenese von SchilddrüsentumorenIn: Deutsche Medizinische Wochenschrift - DMW, Jg. 140, 2015, Nr. 8, S. 578 – 582
-
Morphological and clinical presentation of papillary thyroid carcinoma in children and adolescents of Belarus : the influence of radiation exposure and the source of irradiationIn: Experimental and Molecular Pathology, Jg. 98, 2015, Nr. 3, S. 527 – 531
-
Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour groupIn: British Journal of Cancer (BJC), Jg. 113, 2015, Nr. 12, S. 1704 – 1711DOI (Open Access)
-
Not all DTC patients with N positive disease deserve the attribution "high risk". Contribution of the MSDS trialIn: Journal of Surgical Oncology, Jg. 112, 2015, Nr. 1, S. 9 – 14
-
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): Final results of the multicentre, open-label, randomised, phase 3 trialIn: The Lancet Oncology, Jg. 16, 2015, Nr. 8, S. 979 – 989
-
Pathologie der Nebenschilddrüse : Praktisches für den pathologischen AlltagIn: Der Pathologe, Jg. 36, 2015, Nr. 3, S. 229 – 236
-
Polypen entfernen und wegwerfen? : Wehret den Anfängen!In: Der Pathologe, Jg. 36, 2015, Nr. 2, S. 181
-
Regulation of hematogenous tumor metastasis by acid sphingomyelinaseIn: EMBO Molecular Medicine, Jg. 7, 2015, Nr. 6, S. 714 – 734DOI (Open Access)
-
Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin : a multicenter studyIn: Radiotherapy and Oncology (The Green Journal), Jg. 116, 2015, Nr. 1, S. 119 – 124
-
Rolle der Molekularpathologie beim Schilddrüsenkarzinom : Tumordiagnostik, Zytologie und zielgerichtete TherapieIn: Der Onkologe, Jg. 21, 2015, Nr. 7, S. 584 – 596
-
SOX4, SOX11 and PAX6 mRNA expression was identified as a (prognostic) marker for the aggressiveness of neuroendocrine tumors of the lung by using next-generation expression analysis (NanoString)In: Future Oncology, Jg. 11, 2015, Nr. 7, S. 1027 – 1036
-
Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational statusIn: BMC Cancer, Jg. 15, 2015, Nr. 1, S. 184DOI (Open Access)
-
The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrenceIn: World Journal of Urology, Jg. 33, 2015, Nr. 7, S. 973 – 979
-
Activation of angiogenesis differs strongly between pulmonary carcinoids and neuroendocrine carinomas and is crucial for carcinoid tumourgenesisIn: Journal of Cancer, Jg. 5, 2014, Nr. 6, S. 465 – 471DOI (Open Access)
-
Aggressive treatment of a 51 year old patient with anaplastic thyroid cancer with over one year survivalIn: Experimental and Clinical Endocrinology & Diabetes, Jg. 122, 2014, Nr. 3, S. P025
-
Alveolar and intraparenchymal proteasome in sarcoidosisIn: Respiratory Medicine, Jg. 108, 2014, Nr. 10, S. 1534 – 1541
-
Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung : results of a profiling studyIn: Modern Pathology, Jg. 27, 2014, Nr. 12, S. 1632 – 1640
-
Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancerIn: Human Pathology, Jg. 45, 2014, Nr. 4, S. 674 – 682
-
Gene expression analysis of the 26S proteasome subunit PSMB4 reveals significant upregulation, different expression and association with proliferation in human pulmonary neuroendocrine tumoursIn: Journal of Cancer, Jg. 5, 2014, Nr. 8, S. 646 – 654DOI (Open Access)
-
Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapyIn: Cell Death and Disease, Jg. 5, 2014, Nr. 2, e1091DOI (Open Access)
-
Initial presentation and late results of treatment of post-chernobyl papillary thyroid carcinoma in children and adolescents of BelarusIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 99, 2014, Nr. 8, S. 2932 – 2941DOI (Open Access)
-
Is every PT3A-prostate cancer (PCA) with positive surgical margin a candidate for adjuvant radiation (ARTX)? : Individual risk assessment based on a pathological gleason score predictive model - a multicentre studyIn: The Journal of Urology, Jg. 191, 2014, Nr. Suppl. 4, S. E604
-
Isothermal multiple displacement amplification : a methodical approach enhancing molecular routine diagnostics of microcarcinomas and small biopsiesIn: OncoTargets and Therapy, Jg. 7, 2014, S. 1441 – 1447DOI (Open Access)
-
KRAS, EGFR, PDGFR-α, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE)In: Diagnostic Pathology, Jg. 9, 2014, S. 116DOI (Open Access)
-
Long-term prognosis of patients with pediatric pheochromocytomaIn: Endocrine-Related Cancer, Jg. 21, 2014, Nr. 1, S. 17 – 25DOI (Open Access)
-
Mdm2 protein expression is strongly associated with survival in malignant pleural mesotheliomaIn: Future Oncology, Jg. 10, 2014, Nr. 6, S. 995 – 1005
-
Minimally invasive follicular thyroid cancer (MIFTC) : a consensus report of the European Society of Endocrine Surgeons (ESES)In: Langenbeck's Archives of Surgery, Jg. 399, 2014, Nr. 2, S. 165 – 184
-
Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors) : current strategies in diagnosis and treatment. Conclusions of an Expert Meeting February 2011 in Weimar, Germany
Conclusions of an Expert Meeting February 2011 in Weimar, Germany,In: Oncology Research and Treatment, Jg. 37, 2014, Nr. 5, S. 266 – 276DOI, Online Volltext (Open Access) -
Prognostic effect of serum and tissue YKL-40 levels in bladder cancerIn: Urologic Oncology: Seminars and Original Investigations, Jg. 32, 2014, Nr. 5, S. 663 – 669
-
The impact of claudin-1 on thyroid cancer invasionIn: Experimental and Clinical Endocrinology & Diabetes, Jg. 122, 2014, Nr. 3, S. P023
-
Valproic Acid Downregulates NF-κB p50 Activity and IRAK-1 in a Progressive Thyroid Carcinoma Cell LineIn: Hormone and Metabolic Research, Jg. 46, 2014, Nr. 3, S. 181 – 186
-
A new anastomotic leakage model in circular double stapled colorectal anastomosis after low anterior rectum resection in pigsIn: Journal of Investigative Surgery, Jg. 26, 2013, Nr. 6, S. 364 – 372
-
Cerebral metastases from thyroid carcinoma : complete remission following radioiodine treatmentIn: Deutsches Ärzteblatt International, Jg. 110, 2013, Nr. 50, S. 861 – 866
-
ERCC1, MLH1, MSH2, MSH6, and βiII-tubulin: Resistance proteins associated with response and outcome to platinum-based chemotherapy in malignant pleural mesotheliomaIn: Clinical Lung Cancer, Jg. 14, 2013, Nr. 5, S. 558 – 567
-
Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cellsIn: International Journal of Cancer, Jg. 133, 2013, Nr. 4, S. 908 – 919
-
FFPE tissue as a feasible source for gene expression analysis - A comparison of three reference genes and one tumor markerIn: Pathology, Research and Practice, Jg. 209, 2013, Nr. 12, S. 784 – 789
-
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer CenterIn: European Journal of Cancer (EJC), Jg. 49, 2013, Nr. 15, S. 3076 – 3082
-
German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumorsIn: Langenbeck's Archives of Surgery, Jg. 398, 2013, Nr. 3, S. 347 – 375
-
Glanduläres Papillom des rechten Hauptbronchus : Nachweis einer Exon-2-Mutation des KRAS-Gens (c.35G>A)In: Der Pathologe, Jg. 34, 2013, Nr. 4, S. 338 – 342
-
Increased expression of α-methylacyl-coenzyme A racemase (AMACR; p504s) and p16 in distal hyperplastic polypsIn: Diagnostic Pathology, Jg. 8, 2013, Nr. 1, S. 178
-
Loss of TLR2 worsens spontaneous colitis in MDR1A deficiency through commensally induced pyroptosisIn: The Journal of Immunology (JI), Jg. 190, 2013, Nr. 11, S. 5676 – 5688
-
Neoadjuvant treatment improves capsular integrity and the width of the fibrous capsule of high-grade soft-tissue sarcomasIn: European Journal of Surgical Oncology, Jg. 39, 2013, Nr. 1, S. 61 – 67
-
Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockadeIn: Oncogene, Jg. 32, 2013, Nr. 23, S. 2873 – 2881
-
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsIn: Breast Cancer Research and Treatment, Jg. 142, 2013, Nr. 1, S. 81 – 88
-
Prevalence and Clinical Spectrum of Nonsecretory Medullary Thyroid Carcinoma in a Series of 839 Patients with Sporadic Medullary Thyroid CarcinomaIn: Thyroid, Jg. 23, 2013, Nr. 3, S. 294 – 300
-
Bethesda-Klassifikation der Feinnadelpunktion der Schilddrüse : Viel Lärm um wenig Neues?In: Der Pathologe, Jg. 33, 2012, Nr. 4, S. 324 – 330
-
Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3In: Endocrine-Related Cancer, Jg. 19, 2012, Nr. 3, S. 283 – 290
-
Clinical and Pathologic Features of “Sporadic” Papillary Thyroid Carcinoma Registered in the Years 2005 to 2008 in Children and Adolescents of BelarusIn: Thyroid, Jg. 22, 2012, Nr. 10, S. 1016 – 1024
-
Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity FilterIn: PLoS ONE, Jg. 7, 2012, Nr. 7, S. e41926DOI (Open Access)
-
Der hyalinisierende trabekuläre Tumor der Schilddrüse : Eine übertrieben vorsichtige Bezeichnung für einen gutartigen Tumor?In: Der Pathologe, Jg. 33, 2012, Nr. 2, S. 135 – 141
-
Distinct pattern of oxidative DNA damage and DNA repair in follicular thyroid tumoursIn: Journal of Molecular Endocrinology, Jg. 48, 2012, Nr. 3, S. 193 – 202
-
Euthyroid goiter with and without nodules : Diagnosis and treatmentIn: Deutsches Ärzteblatt International, Jg. 109, 2012, Nr. 29-30, S. 506 – 516
-
Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinomaIn: Clinical Nuclear Medicine, Jg. 37, 2012, Nr. 2, S. 121 – 127
-
Head and neck paragangliomas : Clinical and molecular genetic classificationIn: Clinics, Jg. 67, 2012, Nr. S1, S. 19 – 28
-
High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancerIn: BJU International (BJUI), Jg. 110, 2012, Nr. 6B, S. E308 – E317DOI (Open Access)
-
Impact of HPV status on the response of head and neck cancers to the anti-EGFR antibody cetuximabIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 193 – 193
-
Increase of ABCG2/BCRP + side population stem cells in the myocardium after ventricular unloadingIn: Virchows Archiv, Jg. 461, 2012, Nr. Suppl. 1, S. 263
-
Increase of ABCG2/BCRP+ side population stem cells in myocardium after ventricular unloadingIn: The Journal of Heart and Lung Transplantation, Jg. 31, 2012, Nr. 3, S. 318 – 324
-
MicroRNA-Profile in der Feinnadelbiopsie der SchilddrüseIn: Der Pathologe, Jg. 33, 2012, Nr. 4, S. 331 – 336
-
Minimally invasive cortical-sparing surgery for bilateral pheochromocytomasIn: Langenbeck's Archives of Surgery, Jg. 397, 2012, Nr. 2, S. 233 – 238
-
Sensitivity of fine-needle biopsy in detecting pediatric differentiated thyroid carcinomaIn: Pediatric Blood and Cancer, Jg. 59, 2012, Nr. 2, S. 233 – 237
-
Targeting the anti-apoptotic protein BCL-XL to overcome RAS mediated resistance to anti-EGFR antibody therapy in colorectal cancerIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 253
-
The Action of Small GTPases Rab11 and Rab25 in Vesicle Trafficking During Cell MigrationIn: Cellular Physiology and Biochemistry, Jg. 29, 2012, Nr. 5-6, S. 647 – 656
-
The BRAFV600E Mutation in Papillary Thyroid Carcinoma Is Associated with Glucose Transporter 1 OverexpressionIn: Thyroid, Jg. 22, 2012, Nr. 4, S. 377 – 382
-
Ultrasound-guided fine-needle aspiration biopsy of clinically suspicious thyroid nodules with an automatic aspirator : A novel techniqueIn: Thyroid, Jg. 22, 2012, Nr. 7, S. 695 – 698
-
VVTZ-Tumorprofil - First results of a preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer CenterIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 204 – 204
-
Wie entstehen Schilddrüsentumoren? : Auf dem Weg zu Klassifikation und DifferenzialdiagnostikIn: Unikate: Berichte aus Forschung und Lehre, 2012, Nr. 42: Translationale Krebsforschung: Auf dem Weg zu neuen Therapien, S. 106 – 115DOI, Online Volltext (Open Access)
-
„Rapid on-site evaluation“ (ROSE) in der zytologischen Diagnostik von Lungen- und MediastinalerkrankungenIn: Der Pathologe, Jg. 33, 2012, Nr. 4, S. 308 – 315
-
AKR1B10 expression is associated with less aggressive hepatocellular carcinoma : A clinicopathological study of 168 casesIn: Liver International, Jg. 31, 2011, Nr. 6, S. 812 – 818
-
Chromosomal imbalances in carcinoma showing thymus-like elements (CASTLE)In: Virchows Archiv, Jg. 459, 2011, Nr. 2, S. 221 – 226
-
Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumoursIn: Journal of Clinical Pathology: JCP Online, Jg. 64, 2011, Nr. 6, S. 529 – 535DOI (Open Access)
-
Dissecting Molecular Events in Thyroid Neoplasia Provides Evidence for Distinct Evolution of Follicular Thyroid Adenoma and CarcinomaIn: The American Journal of Pathology, Jg. 179, 2011, Nr. 6, S. 3066 – 3074DOI (Open Access)
-
Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomyIn: International Journal of Cancer, Jg. 128, 2011, Nr. 6, S. 1486 – 1492
-
Expression of GLUT1 is associated with increasing grade of malignancy in non-invasive and invasive urothelial carcinomas of the bladderIn: Oncology Letters, Jg. 2, 2011, Nr. 6, S. 1149 – 1153DOI (Open Access)
-
Expression of HSP 90, PTEN and Bcl-2 in conjunctival melanomaIn: British Journal of Ophthalmology (BJO), Jg. 95, 2011, Nr. 6, S. 853 – 858
-
German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease.In: Langenbeck's Archives of Surgery, Jg. 396, 2011, Nr. 5, S. 639 – 649
-
Germline Mutations of theTMEM127Gene in Patients with Paraganglioma of Head and Neck and Extraadrenal Abdominal SitesIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 96, 2011, Nr. 8, S. E1279 – E1282
-
Growth patterns of lung metastases from sarcomasIn: Virchows Archiv, Jg. 459, 2011, Nr. 2, S. 213 – 219
-
Increased shedding of soluble TNF-receptor 1 during hyperthermic TNF-α-based isolated limb perfusionIn: International Journal of Hyperthermia, Jg. 27, 2011, Nr. 1, S. 33 – 41
-
Individualisierte Therapie durch prädiktive PathologieIn: MMW - Fortschritte der Medizin, Jg. 153, 2011, Nr. 5, S. 25 – 27
-
Monocarboxylate transporter 8 deficiency : Altered thyroid morphology and persistent high triiodothyronine/thyroxine ratio after thyroidectomyIn: European Journal of Endocrinology (EJE), Jg. 165, 2011, Nr. 4, S. 555 – 561
-
Optimierung der Schilddrüsen- Feinnadelpunktion : Automatischer Mikroaspirator versus manuelle TechnikIn: Nuklearmedizin = Nuclear Medicine, Jg. 50, 2011, Nr. 5, S. 189 – 194
-
Pathologische Aufarbeitung von Rektumkarzinomen mit partieller/totaler mesorektaler ExzisionIn: Der Pathologe, Jg. 32, 2011, Nr. 4, S. 321 – 329
-
Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinomaIn: International Journal of Cancer, Jg. 129, 2011, Nr. 10, S. 2390 – 2399
-
Rektale Magenschleimhautheterotopie : Ein Fallbericht in Zusammenschau mit der LiteraturIn: Der Pathologe, Jg. 32, 2011, Nr. 6, S. 521 – 524
-
Simultaneous protection against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR-signaling blockade by oncogenic RASIn: Journal of Clinical Oncology (JCO), Jg. 29, 2011, Nr. Suppl. 4, S. 440
-
TSH compensates thyroid-specific IGF-I receptor knockout and causes papillary thyroid hyperplasiaIn: Molecular Endocrinology, Jg. 25, 2011, Nr. 11, S. 1867 – 1879
-
TTF-1- (Klon 8G7G3/1) positives Kolonkarzinom : Diagnostische ImplikationenIn: Der Pathologe, Jg. 32, 2011, Nr. 4, S. 349 – 351
-
The Toll-like receptor (TLR) 4 variant D299G promotes inflammation-associated colon cancer progression in the intestinal epitheliumIn: Inflammatory Bowel Diseases, Jg. 17, 2011, Nr. Suppl. 2, S. S84
-
The prevalence of the c-kit exon 10 variant, M541L, in aggressive fibromatosis does not differ from the general populationIn: Journal of Clinical Pathology: JCP Online, Jg. 64, 2011, Nr. 11, S. 1021 – 1024
-
Toll-like Receptor 4 Variant D299G Induces Features of Neoplastic Progression in Caco-2 Intestinal Cells and Is Associated With Advanced Human Colon CancerIn: Gastroenterology, Jg. 141, 2011, Nr. 6, S. 2154 – 2165
-
Tumor vascularization and histopathologic regression of soft tissue sarcomas treated with isolated limb perfusion with TNF-α and melphalanIn: Journal of Surgical Oncology, Jg. 103, 2011, Nr. 5, S. 371 – 379
-
Wann ist die Feinnadelbiopsie der Schilddrüse am effektivsten?In: Der Pathologe, Jg. 32, 2011, Nr. 2, S. 169 – 173
-
Zielgerichtete Therapie für Patienten mit SchilddrüsenkarzinomIn: TumorDiagnostik & Therapie, Jg. 32, 2011, Nr. 5, S. 269 – 276
-
14-3-3 sigma and p53 expression in gastric cancer and its clinical applicationsIn: Disease Markers, Jg. 29, 2010, Nr. 1, 470314DOI (Open Access)
-
A novel primary KIT exon 9 single nucleotide substitution c.1427G>T (p.Ser476Ile) in a gastrointestinal stromal tumorIn: Virchows Archiv, Jg. 457, 2010, Nr. 5, S. 623 – 625
-
Aquaporin 1 (AQP1) expression is a novel characteristic feature of a particularly aggressive subgroup of basal-like breast carcinomasIn: Breast Cancer Research and Treatment, Jg. 120, 2010, Nr. 1, S. 67 – 76
-
Attitude of Health Care Professionals to Organ Donation : Two Surveys Among the Staff of a German University HospitalIn: Transplantation Proceedings, Jg. 42, 2010, Nr. 1, S. 126 – 129
-
Benigner Schilddrüsenknoten oder Schilddrüsenmalignom?In: Der Internist, Jg. 51, 2010, Nr. 5, S. 611 – 619
-
Calcitonin screening and pentagastrin testing : Predictive value for the diagnosis of medullary carcinoma in nodular thyroid diseaseIn: European Journal of Endocrinology (EJE), Jg. 162, 2010, Nr. 6, S. 1141 – 1145DOI (Open Access)
-
Clinical implications of molecular studies for the diagnosis of thyroid cancerIn: Hormones, Jg. 9, 2010, Nr. 1, S. 51 – 56DOI (Open Access)
-
Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumoursIn: British Journal of Cancer (BJC), Jg. 102, 2010, Nr. 2, S. 376 – 382DOI, Online Volltext (Open Access)
-
ERCC1 expression in aseptic loosening after total hip replacementIn: Journal of Biomedical Materials Research Part A, Jg. 92, 2010, Nr. 2, S. 556 – 562
-
Epidemiologie, Pathophysiologie, leitliniengerechte Diagnostik und Therapie des SchilddrüsenknotensIn: Medizinische Klinik, Jg. 105, 2010, Nr. 2, S. 80 – 87
-
Expression of MCSP and PRAME in conjunctival melanomaIn: British Journal of Ophthalmology (BJO), Jg. 94, 2010, Nr. 10, S. 1322 – 1327
-
GNAS1 T393C polymorphism and disease progression in patients with malignant melanomaIn: European Journal of Medical Research, Jg. 15, 2010, Nr. 10, S. 422 – 427DOI (Open Access)
-
Hyalinizing trabecular tumour of the thyroid : differential expression of distinct miRNAs compared with papillary thyroid carcinomaIn: Histopathology, Jg. 56, 2010, Nr. 5, S. 632 – 640
-
MET overexpressing chordomas frequently exhibit polysomy of chromosome 7 but no MET activation through sarcoma-specific gene fusionsIn: Tumor Biology, Jg. 31, 2010, Nr. 3, S. 157 – 163
-
Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancerIn: Cancer Science, Jg. 101, 2010, Nr. 5, S. 1300 – 1308DOI (Open Access)
-
Molekularpathologie von SchilddrüsentumorenIn: Der Pathologe, Jg. 31, 2010, Nr. Suppl. 2, S. 229 – 233
-
Multiple endocrine neoplasia type 2In: Best Practice and Research Clinical Endocrinology and Metabolism, Jg. 24, 2010, Nr. 3, S. 371 – 387
-
Neuerungen der TNM-Klassifikation der Kopf-Hals-TumorenIn: Der Pathologe, Jg. 31, 2010, Nr. 5, S. 339 – 343
-
Organspendeprozess an einem Krankenhaus mit MaximalversorgungIn: Deutsche Medizinische Wochenschrift - DMW, Jg. 135, 2010, Nr. 42, S. 2065 – 2070
-
Overexpression of the drug resistance-associated protein metallothionein does not correlate with response of sarcomas to isolated limb perfusion treatmentIn: Journal of Surgical Oncology, Jg. 101, 2010, Nr. 6, S. 465 – 470
-
Pathogenese, Klassifikation und Histologie von SchilddrüsenkarzinomenIn: Der Onkologe, Jg. 16, 2010, Nr. 7, S. 644 – 656
-
Posterior Retroperitoneoscopic Adrenalectomy for Clinical and Subclinical Cushing’s SyndromeIn: World Journal of Surgery, Jg. 34, 2010, Nr. 6, S. 1391 – 1397
-
Posttonsillectomy hemorrhage : Blame on surgeons or genes?In: Laryngoscope, Jg. 120, 2010, Nr. 9, S. 1784 – 1787
-
Primary tumour size is a prognostic parameter in patients suffering from differentiated thyroid carcinoma with extrathyroidal growth : results of the MSDS trialIn: European Journal of Endocrinology (EJE), Jg. 163, 2010, Nr. 4, S. 637 – 644
-
Prognostic impact of plasminogen activator inhibitor type 1 expression in bladder cancerIn: Cancer, Jg. 116, 2010, Nr. 19, S. 4502 – 4512
-
Risk Stratification of Patients with Locally Aggressive Differentiated Thyroid Cancer : Results of a Prospective Multicentre TrialIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 37, 2010, Nr. Suppl. 2, S. 284
-
Risk stratification of patients with locally aggressive differentiated thyroid cancer : Results of the MSDS trialIn: Nuklearmedizin = Nuclear Medicine, Jg. 49, 2010, Nr. 3, S. 79 – 84
-
Systematic comparison of sporadic and syndromic pancreatic islet cell tumorsIn: Endocrine-Related Cancer, Jg. 17, 2010, Nr. 4, S. 875 – 883DOI (Open Access)
-
The XbaI G>T polymorphism of the glucose transporter 1 gene modulates ¹⁸F-FDG uptake and tumor aggressiveness in breast cancerIn: Journal of Nuclear Medicine (JNM), Jg. 51, 2010, Nr. 8, S. 1191 – 1197DOI (Open Access)
-
The mTOR pathway is activated in human autosomal-recessive polycystic kidney diseaseIn: Kidney & Blood Pressure Research, Jg. 33, 2010, Nr. 2, S. 129 – 138
-
The prognostic value of cadherin switch in bladder cancerIn: Oncology Reports, Jg. 23, 2010, Nr. 4, S. 1125 – 1132
-
Using human neural crest-derived progenitor cells to investigate osteogenesis : An in vitro studyIn: Matrix Biology, Jg. 29, 2010, Nr. 3, S. 219 – 227
-
Ventricular unloading is associated with increased 20s proteasome protein expression in the myocardiumIn: The Journal of Heart and Lung Transplantation, Jg. 29, 2010, Nr. 1, S. 125 – 132
-
Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma.In: Hormone and Metabolic Research, Jg. 41, 2009, Nr. 6, S. 475 – 481
-
Association between apoptotis and CD4⁺/CD8⁺ T-lymphocyte ratio in aseptic loosening after total hip replacementIn: International Journal of Biological Sciences, Jg. 5, 2009, Nr. 2, S. 182 – 191DOI (Open Access)
-
Association of GNB4 intron-1 haplotypes with survival in patients with UICC stage III and IV colorectal carcinoma.In: Anticancer Research, Jg. 29, 2009, Nr. 4, S. 1271 – 1274
-
Association of the GNAS1 T393C polymorphism with tumor stage and survival in gastric cancerIn: World Journal of Gastroenterology, Jg. 15, 2009, Nr. 48, S. 6061 – 6067DOI (Open Access)
-
CD4⁺CD25⁺ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosisIn: Nephrology Dialysis Transplantation (NDT), Jg. 24, 2009, Nr. 1, S. 161 – 171DOI (Open Access)
-
COX-2 expression in highly aggressive thyroid malignancies : indication for a possible therapeutic option?In: Hormone and Metabolic Research, Jg. 41, 2009, Nr. 4, S. 314 – 319
-
Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer : Results after 874 patient-years of follow-up in the MSDS-trialIn: Nuklearmedizin = Nuclear Medicine, Jg. 48, 2009, Nr. 3, S. 89 – 98DOI (Open Access)
-
Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinomaIn: International Journal of Colorectal Disease, Jg. 24, 2009, Nr. 11, S. 1287 – 1296
-
Cyclo-oxygenase-2 overexpression is a feature of early and well-differentiated hepatocellular carcinoma with a favourable prognosisIn: Journal of Clinical Pathology: JCP Online, Jg. 62, 2009, Nr. 8, S. 690 – 693
-
DNA repair gene XRCC1 polymorphisms and outcome of renal cell carcinoma in Caucasian patientsIn: Anticancer Research, Jg. 29, 2009, Nr. 12, S. 5131 – 5135
-
Differential expression of microRNA 181b and microRNA 21 in hyperplastic polyps and sessile serrated adenomas of the colonIn: Virchows Archiv, Jg. 455, 2009, Nr. 1, S. 49 – 54
-
EORTC trial 11001 : Distribution of two ¹⁰B-compounds in patients with squamous cell carcinoma of head and neck, a translational research/phase 1 trialIn: Journal of Cellular and Molecular Medicine, Jg. 13, 2009, Nr. 8 B, S. 1653 – 1665
-
Evaluation of 47 soft tissue sarcoma resection specimens after isolated limb perfusion with TNF-α and melphalan : Histologically characterized improved margins correlate with absence of recurrencesIn: Annals of Surgical Oncology, Jg. 16, 2009, Nr. 3, S. 676 – 686
-
Expression of the transcription factor Snail and its target gene Twist are associated with malignancy in pheochromocytomasIn: Annals of Surgical Oncology, Jg. 16, 2009, Nr. 7, S. 1997 – 2005
-
FOXO3a : a novel player in thyroid carcinogenesis?In: Endocrine-Related Cancer, Jg. 16, 2009, Nr. 1, S. 189 – 199
-
Immunocytochemical investigation of Langerin (CD207) is a valuable adjunct in the cytological diagnosis of Langerhans cell histiocytosis of the thyroidIn: Pathology, Research and Practice, Jg. 205, 2009, Nr. 6, S. 433 – 436
-
Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid carcinoma.In: Hormone and Metabolic Research, Jg. 41, 2009, Nr. 6, S. 482 – 487
-
Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors)In: Human Pathology, Jg. 40, 2009, Nr. 12, S. 1706 – 1714
-
Molekularpathologie als Notwendigkeit : Ihre Rolle in der diagnostischen und prädiktiven PathologieIn: Der Pathologe, Jg. 30, 2009, Nr. 2, S. 90 – 93
-
Proteomic identification of aldo-keto reductase AKR1B10 induction after treatment of colorectal cancer cells with the proteasome inhibitor bortezomibIn: Molecular Cancer Therapeutics, Jg. 8, 2009, Nr. 7, S. 1995 – 2006
-
Riesenzelltumoren des Weichgewebes (mit niedrig-malignem Potenzial) in OperationsnarbenIn: Der Pathologe, Jg. 30, 2009, Nr. 5, S. 401 – 406
-
The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinomaIn: Annals of Oncology, Jg. 20, 2009, Nr. 6, S. 1094 – 1099DOI (Open Access)
-
Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic diseaseIn: British Journal of Surgery (BJS), Jg. 96, 2009, Nr. 2, S. 175 – 184
-
Young Man With Kidney Failure and Hemorrhagic Interstitial NephritisIn: American Journal of Kidney Diseases, Jg. 54, 2009, Nr. 6, S. 1162 – 1166
-
Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infectionIn: Journal of Hepatology, Jg. 48, 2008, Nr. 1, S. 83 – 90
-
Aquaporin-1-Expression bei invasiven MammakarzinomenIn: Der Pathologe, Jg. 29, 2008, Nr. Suppl. 2, S. 357 – 362DOI (Open Access)
-
Association study of the G-protein β3 subunit C825T polymorphism with disease progression an overall survival in patients with head and neck squamous cell carcinomaIn: Cancer Epidemiology, Biomarkers & Prevention, Jg. 17, 2008, Nr. 11, S. 3203 – 3207DOI (Open Access)
-
Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosisIn: Nature Medicine, Jg. 14, 2008, Nr. 4, S. 382 – 391DOI (Open Access)
-
Characterization of intron-1 haplotypes of the G protein β4 subunit gene : Association with survival and progression in patients with urothelial bladder carcinomaIn: Pharmacogenetics and Genomics, Jg. 18, 2008, Nr. 11, S. 999 – 1008
-
Decreased Myocardial Chromogranin A Expression and Colocalization With Brain Natriuretic Peptide During Reverse Cardiac Remodeling After Ventricular UnloadingIn: The Journal of Heart and Lung Transplantation, Jg. 27, 2008, Nr. 4, S. 442 – 449
-
Desmoplasia in medullary thyroid carcinoma : A reliable indicator of metastatic potentialIn: Histopathology, Jg. 52, 2008, Nr. 5, S. 623 – 630
-
Differential expression of ghrelin and its receptor (GHS-R1a) in various adrenal tumors and normal adrenal glandIn: Hormone and Metabolic Research, Jg. 40, 2008, Nr. 3, S. 181 – 188
-
Entwicklungen in der diagnostischen Pathologie - Prädiktive Biomarker - Diagnostische Bedeutung der MolekularpathologieIn: Zentralblatt für Chirurgie, Jg. 133, 2008, Nr. 2, S. 89 – 91
-
Evidence for a role of the amyloid precursor protein in thyroid carcinogenesisIn: Journal of Endocrinology, Jg. 198, 2008, Nr. 2, S. 291 – 299
-
Expression and mutation analysis of the tyrosine kinase c-kit in poorly differentiated and anaplastic thyroid carcinomaIn: Hormone and Metabolic Research, Jg. 40, 2008, Nr. 10, S. 685 – 691
-
Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spotIn: World Journal of Surgery, Jg. 32, 2008, Nr. 5, S. 722 – 728
-
Immunohistochemical localization of somatostatin receptor subtypes in benign and malignant adrenal tumoursIn: Clinical Endocrinology, Jg. 68, 2008, Nr. 6, S. 850 – 857
-
Laser postionization secondary neutral mass spectrometry in tissue : A powerful tool for elemental and molecular imaging in the development of targeted drugsIn: Molecular Cancer Therapeutics, Jg. 7, 2008, Nr. 7, S. 1763 – 1771DOI (Open Access)
-
Molekularpathologische Bestimmung prädiktiver Biomarker : Eine neue Aufgabe der diagnostischen PathologieIn: Der Urologe, Jg. 47, 2008, Nr. 10, S. 1298 – 1302
-
Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 geneIn: Clinical Cancer Research, Jg. 14, 2008, Nr. 6, S. 1753 – 1758DOI (Open Access)
-
Retroperitoneoscopic Adrenalectomy in Conn’s Syndrome Caused by Adrenal Adenomas or Nodular HyperplasiaIn: World Journal of Surgery, Jg. 32, 2008, Nr. 5, S. 847 – 853
-
Survivin determines cardiac function by controlling total cardiomyocyte numberIn: Circulation, Jg. 117, 2008, Nr. 12, S. 1583 – 1593
-
Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosisIn: Blood, Jg. 112, 2008, Nr. 8, S. 3312 – 3321DOI, Online Volltext (Open Access)
-
The GNAS1 T393C polymorphism predicts survival in patients with advanced squamous cell carcinoma of the larynxIn: Laryngoscope, Jg. 118, 2008, Nr. 12, S. 2172 – 2176
-
The zinc finger protein and transcriptional repressor Gfi1 as a regulator of the innate immune responseIn: Immunobiology, Jg. 213, 2008, Nr. 3-4, S. 341 – 352
-
Trend reversal in the frequency of mycoses in hematological neoplasiasIn: Deutsches Ärzteblatt International, Jg. 105, 2008, Nr. 28-29, S. 501 – 506DOI (Open Access)
-
Uptake of two ¹⁰B-compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC trial 11001)In: International Journal of Cancer, Jg. 122, 2008, Nr. 5, S. 1164 – 1171DOI (Open Access)
-
Von der Markerexpression zur individuellen Prognoseabschätzung urothelialer NeoplasienIn: Der Urologe, Jg. 47, 2008, Nr. 9, S. 1167 – 1170
-
Wegener’s granulomatosis in the thyroid mimicking a tumourIn: Virchows Archiv, Jg. 452, 2008, Nr. 5, S. 571 – 574
-
AKT and ERK1/2 signaling in intrahepatic cholangiocarcinomaIn: World Journal of Gastroenterology, Jg. 13, 2007, Nr. 48, S. 6470
-
Activation of extracellular regulated kinases (ERK1/2) but not AKT predicts poor prognosis in colorectal carcinoma and is associated with k-ras mutationsIn: Virchows Archiv, Jg. 450, 2007, Nr. 2, S. 151 – 159
-
Characterisation of DEHAL1 expression in thyroid pathologiesIn: European Journal of Endocrinology (EJE), Jg. 156, 2007, Nr. 3, S. 295 – 301
-
Comparison of manual and automated nucleic acid extraction from whole-blood samplesIn: Journal of Clinical Laboratory Analysis, Jg. 21, 2007, Nr. 4, S. 244 – 248DOI (Open Access)
-
Diffuse sclerosing variant of papillary thyroid carcinoma : Lack of BRAF mutation but occurrence of RET/PTC rearrangementsIn: Modern Pathology, Jg. 20, 2007, Nr. 7, S. 779 – 787DOI (Open Access)
-
Double resistance to imatinib and AMG 706 caused by multiple acquired KIT exon 17 mutations in a gastrointestinal stromal tumourIn: Gut, Jg. 56, 2007, Nr. 7, S. 1025 – 1026DOI (Open Access)
-
Einsatz der Siliziumchiptechnologie zur Detektion von Tumormarkern auf Proteinbasis beim HarnblasenkarzinomIn: Der Urologe, Jg. 46, 2007, Nr. 9, S. 1152 – 1156
-
Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinomaIn: Virchows Archiv, Jg. 450, 2007, Nr. 2, S. 135 – 141DOI (Open Access)
-
GNAS1 T393C polymorphism is associated with clinical course in patients with intrahepatic cholangiocarcinomaIn: Neoplasia: An International Journal for Oncology Research, Jg. 9, 2007, Nr. 2, S. 159 – 165DOI (Open Access)
-
Gründung einer Arbeitsgruppe „Lymphknotenmetastasierung“ am Westdeutschen Tumorzentrum (WTZE), Universitätsklinikum EssenIn: Der Urologe, Jg. 46, 2007, Nr. 9, S. 1257 – 1260
-
Identifikation der molekularen Grundlagen der Metastasierung zur Entwicklung neuer Therapiestrategien des metastasierten ProstatakarzinomsIn: Der Urologe, Jg. 46, 2007, Nr. 9, S. 1261 – 1262
-
Immigrating progenitor cells contribute to human podocyte turnoverIn: Kidney International, Jg. 72, 2007, Nr. 12, S. 1468 – 1473DOI (Open Access)
-
Induction of the matrix metalloproteinase-2 activation system in arteries by tensile stress. Involvement of the p38 MAP-kinase pathwayIn: Pathology, Research and Practice, Jg. 203, 2007, Nr. 3, S. 135 – 143
-
Metallothionein in bladder cancer : Correlation of overexpression with poor outcome after chemotherapyIn: World Journal of Urology, Jg. 25, 2007, Nr. 2, S. 199 – 205
-
Novel germ cell markers characterize testicular seminoma and fetal testisIn: Molecular Human Reproduction: MHR, Jg. 13, 2007, Nr. 10, S. 721 – 727
-
Proapoptotische Antikörper als neue TumortherapeutikaIn: Der Urologe, Jg. 46, 2007, Nr. 9, S. 1262 – 1265
-
Roles of cyclooxygenase-2 and phosphorylated Akt ⁽Thr³⁰⁸⁾ in cardiac hypertrophy regression mediated by left-ventricular unloadingIn: Journal of Thoracic and Cardiovascular Surgery, Jg. 133, 2007, Nr. 1, S. 37 – 43DOI (Open Access)
-
The AA genotype of the regulatory BCL2 promoter polymorphism (-938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patientsIn: Clinical Cancer Research, Jg. 13, 2007, Nr. 19, S. 5790 – 5797DOI (Open Access)
-
The C allele of the GNB3 C825T polymorphism of the G protein β3-subunit is associated with an increased risk for the development of oncocytic thyroid tumoursIn: The Journal of Pathology, Jg. 211, 2007, Nr. 1, S. 60 – 66
-
The T393C polymorphism in the gene GNAS1 of G protein is associated with survival of patients with invasive breast carcinomaIn: Breast Cancer Research and Treatment, Jg. 105, 2007, Nr. 3, S. 311 – 317
-
Zystischer Pankreasprozess – Ist das Pankreas stets das Primärorgan?In: Der Gastroenterologe, Jg. 2, 2007, Nr. 4, S. 268 – 271
-
Development of a neuroblastoma-specific tissue-microarray as a tool for time- and cost-effective immunohistochemistry analysesIn: Klinische Pädiatrie, Jg. 218, 2006, Nr. 3, S. 195
-
Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal massIn: European Journal of Endocrinology, Jg. 154, 2006, Nr. 3, S. 409 – 417DOI (Open Access)
-
EpCAM overexpression in thyroid carcinomas : A histopathological study of 121 casesIn: Journal of Immunotherapy, Jg. 29, 2006, Nr. 5, S. 569 – 573
-
How to define follicular thyroid carcinoma?In: Virchows Archiv, Jg. 448, 2006, Nr. 4, S. 385 – 393
-
Increased frequencies of CD8+ T lymphocytes recognizing wild-type p53-derived epitopes in peripheral blood correlate with presence of epitope loss tumor variants in patients with hepatocellular carcinomaIn: International Journal of Cancer, Jg. 119, 2006, Nr. 12, S. 2851 – 2860DOI (Open Access)
-
Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paragangliomas: Results of 161 tumors in 126 patientsIn: World Journal of Surgery, Jg. 30, 2006, Nr. 5, S. 899 – 908
-
Liver transplantation for patients with metastatic endocrine tumors : Single-center experience with 15 patientsIn: Liver Transplantation, Jg. 12, 2006, Nr. 7, S. 1089 – 1096DOI (Open Access)
-
No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemiaIn: Pharmacogenetics and Genomics, Jg. 16, 2006, Nr. 11, S. 783 – 788
-
Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathwaysIn: Journal of Clinical Pathology: JCP Online, Jg. 59, 2006, Nr. 7, S. 685 – 691DOI (Open Access)
-
Posterior retroperitoneoscopic adrenalectomy-results of 560 procedures in 520 patientsIn: Surgery, Jg. 140, 2006, Nr. 6, S. 943 – 950
-
Recurrent high-grade leiomyosarcoma with heterologous osteosarcomatous differentiationIn: Virchows Archiv, Jg. 448, 2006, Nr. 1, S. 85 – 89
-
Relationship and prognostic significance of phospho-(serine 166)-murine double minute 2 and Akt activation in node-negative breast cancer with regard to p53 expressionIn: Virchows Archiv, Jg. 448, 2006, Nr. 1, S. 16 – 23
-
The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinomaIn: Clinical Cancer Research, Jg. 12, 2006, Nr. 3, S. 759 – 763DOI (Open Access)
-
The zinc finger protein Gfi1 acts upstream of TNF to attenuate endotoxin-mediated inflammatory responses in the lungIn: European Journal of Immunology, Jg. 36, 2006, Nr. 2, S. 421 – 430DOI (Open Access)
-
Therapiebedingte Veränderungen der SchilddrüseIn: Der Pathologe, Jg. 27, 2006, Nr. 1, S. 13 – 18
-
Unusual aggressive course of a giant cell tumor of soft tissue during immunosuppressive therapyIn: Virchows Archiv, Jg. 448, 2006, Nr. 6, S. 847 – 851
-
Der intraoperative Gefrierschnitt von Schilddrüsenknoten : Indikation - Verlässlichkeit - GrenzenIn: Viszeralchirurgie, Jg. 40, 2005, Nr. 3, S. 174 – 179
-
Different genotype distribution of the GNB3 C825T polymorphism of the G protein β3 subunit in adenomas and differentiated thyroid carcinomas of follicular cell originIn: The Journal of Pathology, Jg. 207, 2005, Nr. 4, S. 430 – 435
-
Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal glandIn: Hormone and Metabolic Research, Jg. 37, 2005, Nr. 12, S. 722 – 728
-
Empfehlungen und offene Fragen in der Diagnostik und Therapie von Schilddrüsenknoten : Stellungnahme der Sektion Schilddrüse der Deutschen Gesellschaft für EndokrinologieIn: Deutsche Medizinische Wochenschrift: DMW, Jg. 130, 2005, Nr. 31-32, S. 1831 – 1836
-
Endoscopic treatment of large primary adrenal tumoursIn: British Journal of Surgery, Jg. 92, 2005, Nr. 6, S. 719 – 723
-
GNAS1 T393C polymorphism and survival in patients with sporadic colorectal cancerIn: Clinical Cancer Research, Jg. 11, 2005, Nr. 14, S. 5071 – 5077DOI (Open Access)
-
Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4In: Cellular and Molecular Life Sciences - CMLS, Jg. 62, 2005, Nr. 19-20, S. 2359 – 2368
-
Guidelines on radioiodine therapy for differentiated thyroid carcinoma : Impact on clinical practiceIn: Nuklearmedizin = Nuclear Medicine, Jg. 44, 2005, Nr. 6, S. 229 – 237
-
High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome.In: Breast Cancer Research : BCR, Jg. 7, 2005, Nr. 2DOI (Open Access)
-
Paraganglioma-like medullary thyroid carcinoma : A rare entityIn: Thyroid, Jg. 15, 2005, Nr. 12, S. 1363 – 1367
-
Prinzipielle Probleme der LymphknotenchirurgieIn: Der Urologe: Ausgabe A, Jg. 44, 2005, Nr. 6, S. 605 – 607
-
Prognostic value of c-erbB-2 expression in papillary thyroid carcinomaIn: Nuklearmedizin = Nuclear Medicine, Jg. 44, 2005, Nr. 5, S. 179 – 184
-
Reverse remodeling following insertion of left ventricular assist devices (LVAD) : A review of the morphological and molecular changesIn: Cardiovascular Research, Jg. 68, 2005, Nr. 3, S. 376 – 386DOI (Open Access)
-
The T393C polymorphism of the Gαs gene (GNAS1) is a novel prognostic marker in bladder cancerIn: Cancer Epidemiology, Biomarkers & Prevention, Jg. 14, 2005, Nr. 4, S. 871 – 877DOI (Open Access)
-
Erdheim-Chester disease : Case report with multisystemic manifestations including testes, thyroid, and lymph nodes, and a review of literatureIn: Journal of Clinical Pathology: JCP Online, Jg. 57, 2004, Nr. 11, S. 1225 – 1228DOI (Open Access)
-
Heat shock protein 72 and apoptosis indicate cardiac decompensation during early multiple organ failure in sheepIn: Intensive Care Medicine, Jg. 30, 2004, Nr. 7, S. 1405 – 1413
-
Immunohistochemical determination of somatostatin receptor subtypes 1, 2A, 3, 4, and 5 in various adrenal tumorsIn: Endocrine Research, Jg. 30, 2004, Nr. 4, S. 931 – 934
-
Impact of disease activity on thyroid diseases in patients with acromegaly : Basal evaluation and follow-upIn: Experimental and Clinical Endocrinology & Diabetes, Jg. 112, 2004, Nr. 5, S. 225 – 230
-
Partial versus total adrenalectomy by the posterior retroperitoneoscopic approach : Early and long-term results of 325 consecutive procedures in primary adrenal neoplasiasIn: World Journal of Surgery, Jg. 28, 2004, Nr. 12, S. 1323 – 1329
-
Pericarditis constrictiva mit Perikarderguss : Schwierige Diagnose mit erheblichen therapeutischen KonsequenzenIn: Herz: Cardiovascular Diseases, Jg. 29, 2004, Nr. 5, S. 563 – 567
-
Prognostic relevance of activated Akt kinase in node-negative breast cancer : A clinicopathological study of 99 casesIn: Modern Pathology, Jg. 17, 2004, Nr. 1, S. 15 – 21DOI (Open Access)
-
31-year-old injection drug user with massive skin necrosis and shockIn: Dermatology, Jg. 206, 2003, Nr. 2, S. 169 – 171
-
Biochips in der Entwicklung für das HarnblasenkarzinomIn: Der Urologe: Ausgabe A, Jg. 42, 2003, Nr. 7, S. 927 – 932
-
Diagnostic value of high-resolution B-mode and power-mode sonography in the follow-up of thyroid cancerIn: European Journal of Ultrasound, Jg. 16, 2003, Nr. 3, S. 191 – 206
-
Diagnostic value of high-resolution B-mode and power-mode sonography in the follow-up of thyroid cancerIn: European Journal of Ultrasound, Jg. 16, 2003, Nr. 3, S. 191 – 206
-
Entzündliche Schilddrüsenerkrankungen : Epidemiologie, Klinik und MorphologieIn: Der Pathologe, Jg. 24, 2003, Nr. 5, S. 339 – 347
-
Expression of Galectin-3 in Normal and Malignant Thyroid Tissue by Quantitative PCR and ImmunohistochemistryIn: Modern Pathology, Jg. 16, 2003, Nr. 11, S. 1117 – 1123DOI (Open Access)
-
Hyperplasien und Tumoren der NebenschilddrüsenIn: Der Pathologe, Jg. 24, 2003, Nr. 5, S. 373 – 381
-
Identification of Two Distinct Subpopulations in a Ganglioneuroblastoma : Lack of Co-Localization of Vasoactive Intestinal Polypeptide and Calcitonin in Ganglionic Cells at the Ultrastructural LevelIn: Medical and Pediatric Oncology, Jg. 41, 2003, Nr. 6, S. 571 – 573
-
Lung cancer during pregnancy involving the products of conception and a review of the literatureIn: Archives of Gynecology and Obstetrics, Jg. 268, 2003, Nr. 2, S. 69 – 77
-
RET rearrangements in archival oxyphilic thyroid tumors : New insights in tumorigenesis and classification of Hürthle cell carcinomas?In: Surgery, Jg. 134, 2003, Nr. 6, S. 881 – 889
-
Rare expression of target antigens for immunotherapy on disseminated tumor cells in breast cancer patients without overt metastasesIn: International Journal of Molecular Medicine, Jg. 12, 2003, Nr. 6, S. 969 – 975
-
Rasch progrdientes Rezidiv der kolumnären Variante eines papillären Schilddrüsenkarzinoms unter endogener TSH-StimulationIn: Nuklearmedizin = Nuclear Medicine, Jg. 42, 2003, Nr. 3, S. N15 – 18
-
Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinomaIn: World Journal of Surgery, Jg. 26, 2002, Nr. 3, S. 390 – 396
-
Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor GFi1In: Nature Genetics, Jg. 30, 2002, Nr. 3, S. 295 – 300
-
Metallothionein : Early marker in the carcinogenesis of ulcerative colitis-associated colorectal carcinomaIn: World Journal of Surgery, Jg. 26, 2002, Nr. 6, S. 726 – 731
-
Mimikri einer multiplen endokrinen Neoplasie mit Schilddrüsenbeteiligung durch das Spätrezidiv eines NierenzellkarzinomsIn: Nuklearmedizin = Nuclear Medicine, Jg. 41, 2002, Nr. 3, S. N24 – 26
-
Modulation of radiation-induced tumour necrosis factor α (TNF-α) expression in the lung tissue by pentoxifyllineIn: Radiotherapy and Oncology (The Green Journal), Jg. 64, 2002, Nr. 2, S. 177 – 187
-
Purpura fulminans : Fatale Folge einer alltäglichen Therapie?In: Der Hautarzt, Jg. 53, 2002, Nr. 7, S. 483 – 487
-
Increased expression of metallothionein in inflammatory bowel diseaseIn: Inflammation Research, Jg. 50, 2001, Nr. 6, S. 289 – 293
-
Dose-dependent induction of transforming growth factor β (TGF-β) in the lung tissue of fibrosis-prone mice after thoracic irradiationIn: International Journal of Radiation Oncology, Biology, Physics, Jg. 47, 2000, Nr. 4, S. 1033 – 1042
-
Potential embolization by atherosclerotic debris dislodged from aortic wall during cardiac catheterization : Histological and clinical findings in 7,621 patientsIn: Catheterization and Cardiovascular Interventions, Jg. 49, 2000, Nr. 4, S. 389 – 394
-
Differential effects of angiotensin II receptor blockade on pressure-induced left ventricular hypertrophy and fibrosis in ratsIn: Journal of Molecular and Cellular Cardiology, Jg. 31, 1999, Nr. 2, S. 445 – 455
-
Immunophenotypic analysis of normal mucosa and squamous cell carcinoma of the oral cavityIn: Cancer Detection and Prevention, Jg. 23, 1999, Nr. 1, S. 45 – 56
-
Kikuchi-Fusimoto-Disease : Differentialdiagnose einer zervikalen Lymphadenitis mit rezidivierenden FieberschübenIn: Deutsche Medizinische Wochenschrift - DMW, Jg. 124, 1999, Nr. 8, S. 213 – 216
-
Mean weighted nuclear volumes in colonic adenocarcinomas : Evaluation of prognostic significanceIn: Analytical and Quantitative Cytology and Histology, Jg. 21, 1999, Nr. 3, S. 194 – 200
-
Murine leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their precursorsIn: Journal of Leukocyte Biology, Jg. 65, 1999, Nr. 2, S. 217 – 231DOI (Open Access)
-
Prognostic value of lymphocyte apoptosis in acute rejection of renal allograftsIn: Transplantation, Jg. 67, 1999, Nr. 4, S. 581 – 585
-
Standardized in situ AgNOR analysis in breast pathology : Diagnostic and cell kinetic implicationsIn: Pathology, Research and Practice, Jg. 195, 1999, Nr. 4, S. 219 – 229
-
Transepithelial transport processes at the intestinal mucosa in inflammatory bowel diseaseIn: International Journal of Colorectal Disease, Jg. 14, 1999, Nr. 1, S. 41 – 46
-
Decreased HER-2 tyrosine kinase expression in rectal mucosa of FAP patients following low-dose sulindac chemopreventionIn: Cancer Letters, Jg. 134, 1998, Nr. 2, S. 201 – 207
-
Open Access publizieren dank DEAL-Vereinbarung : Geben Sie Ihren wissenschaftlichen Beiträgen die größtmögliche VerbreitungIn: Der Pathologe. Heidelberg; Berlin; Heidelberg [u.a.]: Springer Medizin, Jg. 41, 2020, Nr. 3, S. 207 – 208DOI (Open Access)
-
„Pitfalls“ und „besondere Fälle“ in der diagnostischen Pathologie : Zum Wechsel der Rubrik-HerausgeberschaftIn: Der Pathologe. Heidelberg; Berlin; Heidelberg [u.a.]: Springer Medizin, Jg. 41, 2020, Nr. 5, S. 431DOI (Open Access)
-
40 Jahre Der PathologeIn: Der Pathologe. Heidelberg; Berlin; Heidelberg [u.a.]: Springer Medizin, Jg. 40, 2019, Nr. 1DOI (Open Access)
-
„Yes, we care“ : Präzisionsonkologie, endokrine Pathologie, Transplantationspathologie und Geschichte der PathologieIn: Der Pathologe. Heidelberg; Berlin; Heidelberg [u.a.]: Springer Medizin, Jg. 40, 2019, Nr. 3, S. 209 – 210DOI (Open Access)
-
Die olympische Devise der PathologieIn: Der Pathologe. Heidelberg; Berlin; Heidelberg [u.a.]: Springer Medizin, Jg. 38, 2017, Nr. 1, S. 1 – 2
-
Pitfalls : eine neue Rubrik in Der PathologeIn: Der Pathologe. Heidelberg; Berlin; Heidelberg [u.a.]: Springer Medizin, Jg. 33, 2012, Nr. 2, S. 93
-
Zur Übernahme der SchriftleitungIn: Der Pathologe. Heidelberg; Berlin; Heidelberg [u.a.]: Springer Medizin, Jg. 31, 2010, Nr. 6, S. 409
-
The single nucleotide polymorphism rs7121 in the gene GNAS as a biomarker for tumor progression and poor survival in intrahepatic cholangiocellular carcinoma patients
8th German Pharm-Tox Summit 2023, 06.-09.03.2023, Ulm,In: Naunyn-Schmiedeberg's Archives of Pharmacology. Berlin: Springer, Jg. 396, 2023, Nr. Supplement 1: 8th German Pharm-Tox Summit 2023 Abstracts of the 89. Jahrestagung der Deutschen Gesellschaft für Experimentelle und Klinische Pharmakologie und Toxikologie (DGPT) in Zusammenarbeit mit der AGAH, S. S46DOI (Open Access) -
Apoptotische Gastritis nach Immuncheckpointblockade : Ein typisches histopathologisches MusterIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 18, 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. P12DOI (Open Access)
-
Patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC) show highly favorable outcomes with treatment sequences provided at a comprehensive cancer center
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment. Basel: Karger, Jg. 43, 2020, Nr. Suppl. 4, S. 137DOI (Open Access) -
A prospective, randomized, single blinded multicentre trial to evaluate molecular genetic characterisation of primary diagnosed or relapsed non small cell lung cancer by single or combination of diagnostic procedures : The PROFILER study
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 42, 2019, Nr. Supplement 4: Abstracts, S. 213 – 214DOI (Open Access) -
Immunohistochemically Detectable Metallothionein Expression in Malignant Pleural Mesotheliomas is Strongly Associated with Early Failure to Platin-Based Chemotherapy
Herbsttagung der Sektion Zellbiologie in der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., Essen, 09.–10.11.2018,In: Pneumologie. Stuttgart: Thieme, Jg. 73, 2019, Nr. 02, S. 110 – 111 -
In a Novel Malignant Pleural Effusion Derived Anaplastic Thyroid Cancer Line PD-L1 Expression is Strongly Increased by HDAC Inhibitor Treatment
Herbsttagung der Sektion Zellbiologie in der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., Essen, 09.–10.11.2018,In: Pneumologie. Stuttgart: Thieme, Jg. 73, 2019, Nr. 02, S. 111 -
Influence of Methallothionein Expression on Sensitivity Against Platin Compounds in Human Malignant Pleural Mesothelioma Cell Lines – Knock-Down of Gene Expression as New Therapeutic Approach?
Herbsttagung der Sektion Zellbiologie in der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., Essen, 09.–10.11.2018,In: Pneumologie. Stuttgart: Thieme, Jg. 73, 2019, Nr. 02, S. 115 -
Processing Escapes : an Alternative Explanation for Immune Therapy Resistance
Herbsttagung der Sektion Zellbiologie in der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., Essen, 09.–10.11.2018,In: Pneumologie. Stuttgart: Thieme, Jg. 73, 2019, Nr. 02, S. 111 – 112 -
Processing Escapes : Novel Resistance Mechanisms Under Immune Checkpoint Inhibition in NSCLCIn: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 14, 2019, Nr. 10, Supplement, S. S450DOI (Open Access)
-
Acute Myeloid Leukemia Induced Remodelling of the Human Bone Marrow Niche Predicts Clinical Outcome
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 132, 2018, Nr. Supplement 1, S. 3851 – 3851DOI (Open Access) -
BRCAness phenotype is common in MPM and is associated with response to olaparib in vitro
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 175DOI (Open Access) -
Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor, synchronous axillary lymph node metastases and circulating tumor cells in early breast cancer patients
2017 San Antonio Breast Cancer Symposium ; December 5-9, 2017, San Antonio, Texas,In: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 78, 2018, Nr. 4, Supplement, S. PD3 – 02DOI (Open Access) -
Development of predictors for PD-1/PD-L1-directed therapy of non-small cell lung cancer (NSCLC) by gene expression profiling of small diagnostic biopsies (DBX)In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 36, 2018, Nr. 15 Suppl., S. e15121DOI (Open Access)
-
Evaluation of prognostic markers in patients (pts) with advanced gastric cancer (GC) and adenocarcinoma of the gastroesophageal junction (AEG) treated with systemic chemothearpy (ctx) at the West German Cancer Center
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 67DOI (Open Access) -
Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 115DOI (Open Access) -
Inhibition of MDM2 via Nutlin-3A : A potential therapeutic approach for pleural mesotheliomas with MDM2-induced inactivation of P53
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 175DOI (Open Access) -
Mass Spectrometry based Methylation Analysis of MDM2, CDKN2A, RB1, TP53 and TP73 and Associations to MDM2 Overexpression in Malignant Pleural mesothelioma
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 115DOI (Open Access) -
Potentially Targetable Molecular Alterations in 70 Cases of Urachal Cancer
Geared to Learn ; USCAP 107th Annual Meeting ; March 17–23, 2018, Vancouver,In: Modern Pathology. Amsterdam: Elsevier, Jg. 31, 2018, Nr. Suppl. 2, S. 378DOI (Open Access) -
Processing escape mechanisms through alterated proteasomal cleavage of epitopes affects immune response in pulmonary neuroendocrine tumors
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 176DOI (Open Access) -
Signaling network activation in colorectal cancer : p70S6K phosphorylation as a prognostic marker
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 55DOI (Open Access) -
The prognostic impact of UDP-glucuronyltransferase 1A1*1 (UGT1A1*1) polymorphism in patients with advanced colorectal and non-colorectal cancer treated with irinotecan-based systemic chemotherapies
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 122 – 123DOI (Open Access) -
Association between tumor infiltrating immune cells and disseminated tumor cells in the bone marrow of patients with primary breast cancer : A ten year follow-upIn: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 76, 2016, Nr. 4 Suppl., P4-04-07
-
Evaluation of prognostic markers in patients (pts) with metastatic colorectal cancer (mCRC) treated with a bevacizumab (bev) based chemotherapy (ctx) at the West German Cancer Center
Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,In: Oncology Research and Treatment. Basel: Karger, Jg. 39, 2016, Nr. Suppl. 1, S. 77 -
Evaluation of systemic inflammatory response (SIR) markers in recurrent or metastatic head and neck squamous cell carcinoma (r/m HNSCC)In: Oncology Research and Treatment. Basel: Karger, Jg. 39, 2016, Nr. Suppl. 3, S. 307 – 308
-
Identification of prognostic and predictive biomarkers in malignant pleural mesothelioma in 134 patients from two research sites (Berlin and Essen)
Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,In: Oncology Research and Treatment. Basel: Karger, Jg. 39, 2016, Nr. Suppl. 1, S. 123 -
Evaluation of systemic inflammatory response (SIR) markers in advanced biliary tract cancer (ABTC)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,In: Oncology Research and Treatment. Basel: Karger, Jg. 38, 2015, Nr. Suppl. 5, S. 5 – 6 -
Evaluation of systemic inflammatory response (SIR) markers in pancreatic ductal adenocarcinoma (PDAC)In: Oncology Research and Treatment. Basel: Karger, Jg. 38, 2015, Nr. S 5, Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz, S. 4 – 5
-
FNTB promoter polymorphisms influence survival in prostate cancer
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,In: Oncology Research and Treatment. Basel: Karger, Jg. 38, 2015, Nr. Suppl. 5, S. 80 -
Prognostische Faktoren bei Patienten mit fortgeschrittenen Pankreaskarzinomen, die am Westdeutschen Tumorzentrum (WTZ) sequentielle Chemotherapien erhalten haben
121. Kongress der Deutschen Gesellschaft für Innere Medizin ; DGIM 2015 ; 18. - 21. April 2015, Mannheim, Germany,In: Der Internist. Berlin: Springer Medizin, Jg. 56, 2015, Nr. Supplement 1: Abstracts zum 121. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., S. 38 – 39 -
Prognostische Faktoren bei Patienten mit fortgeschrittenen cholangiozellulären Karzinomen, die am Westdeutschen Tumorzentrum (WTZ) sequentielle Chemotherapien erhalten haben
121. Kongress der Deutschen Gesellschaft für Innere Medizin ; DGIM 2015 ; 18. - 21. April 2015, Mannheim, Germany,In: Der Internist. Berlin: Springer Medizin, Jg. 56, 2015, Nr. Supplement 1: Abstracts zum 121. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., S. 37 -
Heterogeneity in the Ki-67 Index of Neuroendocrine Tumors
11th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, March 5-7, 2014,In: Neuroendocrinology. Basel: Karger, Jg. 99, 2014, Nr. 3-4, S. 249 -
Impact of human papilloma virus infection on the response of head and neck cancers (HNSCC) to anti-epidermal growth factor receptor (EGFR) antibody therapy
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 76 -
Molecular and clinical predictors of the efficacy of cetuximab in combination with mFOLFOX6 in 1st line treatment of patients (pts) with metastatic colorectal cancer (mCRC) : subgroup analyses of the CEBIFOX trial
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 5, S. 100 – 101 -
Outcome of patients (pts) with advanced pancreaticobiliary cancers treated with sequential chemotherapies at the West German Cancer Center (WTZ)
Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 51 -
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsIn: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1: 31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie Berlin, 19.-22. Februar 2014: Abstracts, S. 19DOI (Open Access)
-
Prognostic factors in patients (pts) with advanced cholangiocellular carcinoma (CCC) receiving sequential chemotherapies (CTX) at the West German Cancer Center (WTZ)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 5, S. 122 – 123 -
Prognostic factors in patients with pancreatic cancer receiving sequential chemotherapies (CTX) at the West German Cancer Center (WTZ), one of the 12 Oncology Centers of Excellence in Germany
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 5, S. 123 – 124 -
TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutationIn: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 32, 2014, Nr. 15, Suppl., S. 8109
-
TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 92 -
WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 2 – 3 -
Molecular dissection of effector mechanisms of RAS-induced resistance to monoclonal anti-EGFR antibodies
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,In: Onkologie. Basel: Karger, Jg. 36, 2013, Nr. Suppl. 7, S. 116 – 117 -
Outcome of patients (pts) with advanced pancreaticobiliary cancers treated with sequential chemotherapies at the West German Cancer Center (WTZ), one of the 11 Oncology Centers of Excellence in Germany
17 Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,In: Onkologie. Basel: Karger, Jg. 36, 2013, Nr. Suppl. 7, S. 263 -
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastastic breast cancer patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,In: Oncology Research and Treatment. Basel: Karger, Jg. 36, 2013, Nr. Suppl. 7, S. 157 -
TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutationIn: Onkologie. Basel: Karger, Jg. 36, 2013, Nr. Suppl. 7, S. 30
-
Try : a phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutationIn: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 8, 2013, Nr. Suppl. 2, S. S914 – S915DOI (Open Access)
-
Impact of EGFR mutation status on clinical benefit from BIBW 2992 in patients (PTS) with advanced non-small lung cancer (NSCLC) progressing after chemotherapy (CTX) and erlotinib (E) or gefitinib (G) : a single center experience
37th ESMO Congress, 28 September - 2 October 2012, Vienna, Austria,In: Annals of Oncology. Amsterdam: Elsevier, Jg. 23, 2012, Nr. Suppl. 9, S. 437 – 438 -
Competing risks analysis and long-term survival (LTS) of patients (PTS) with locally advanced (LAD) stage III non-small- cell lung cancer (NSCLC) treated on sequential trimodality (TM) trials
14th World Conference on Lung Cancer (WCLC), July 03 - 07, 2011, Amsterdam, The Netherlands,In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 6, 2011, Nr. 6, Suppl. 2, S. S376 – S377 -
Primary Tumour Size is a Prognostic Parameter in Patients Suffering from Differentiated Thyroid Carcinoma with Extrathyroidal Growth : Results of a Prospective Multicentre MSDS TrialIn: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 37, 2010, Nr. Suppl. 2, S. S283 – S284
-
Advances in the diagnosis and surgical management of medullary thyroid carcinomasIn: Advances in Treatment and Management in Surgical Endocrinology / Shifrin, Alexander L. (Hrsg.): Elsevier, 2019, S. 11 – 25
-
Post-Chernobyl Pediatric Papillary Thyroid Carcinoma in Belarus : Histopathological Features, Treatment Strategy, and Long-Term OutcomeIn: Thyroid Cancer and Nuclear Accidents: Long-Term Aftereffects of Chernobyl and Fukushima / Yamashita, Shunichi; Thomas, Gerry (Hrsg.). London: Elsevier Inc., 2017, S. 49 – 58
-
Histopathology of C Cells and Medullary Thyroid CarcinomaIn: Medullary Thyroid Carcinoma. Cham: Springer, 2015, S. 41 – 60
-
Histopathology of C cells and medullary thyroid carcinoma : biology, management, treatmentIn: Medullary Thyroid Carcinoma / Raue, Friedhelm (Hrsg.). Cham [u.a.]: Springer, 2015, S. 41 – 60
-
Epidermal growth factor receptor as a novel therapeutic target in anaplastic thyroid carcinomasIn: Signal Transduction Pathways, Chromatin Structures, and Gene Expression Mechanisms as Therapeutic Targets. New York: New York Academy of Sciences, 2004, S. 69 – 77
-
Immuntherapie eines Mikrosatelliten-instabilen metastasierten Talgdrüsenkarzinoms der Glandula submandibularis mit Pembrolizumab
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,In: Oncology Research and Treatment. Basel: Karger, Jg. 45, 2022, Nr. Supplement 2, S. 230 – 231DOI (Open Access) -
Efficacy of immunotherapy (IO) and subsequent systemic treatment after failure of IO in patients with recurrent or metastatic head and neck cancer in a real-world setting
ESMO Congress 2021, 16 – 21 September 2021, Virtual,In: Annals of Oncology. Amsterdam: Elsevier, Jg. 32, 2021, Nr. Suppl. 5, S. S812DOI (Open Access) -
MCT 8 and LAT 2 expression in differentially functioning benign and malignant thyroid tumors
57th Symposium of the German Society of Endocrinology (DGE), 19th–22th March, 2014, Dresden, Germany,In: Experimental and Clinical Endocrinology & Diabetes. Stuttgart: Thieme, Jg. 122, 2014, Nr. 3, P082 -
Decrease of circulating tumor cells associates with response to platinum-based chemotherapy in patients with non-small cell lung cancer, but not with small cell lung cancer
14th World Conference on Lung Cancer (WCLC), July 03 - 07, 2011, Amsterdam, The Netherlands,In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 6, 2011, Nr. 6, Suppl. 2, S. S1114 -
Highly sensitive detection of somatic epidermal growth factor receptor (EGFR) gene mutations in circulating tumor cells (CTC) from patients with non-small cell lung cancer treated with cisplatin/pemetrexed or afatinib
14th World Conference on Lung Cancer, July 3 – 7, 2011, Amsterdam, The Netherlands,In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 6, 2011, Nr. 6, Suppl. 2, S. S956 – S957